Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CK Life Sciences Int'l., (Holdings) Inc.
  6. News
  7. Summary
    775   KYG2176J1058

CK LIFE SCIENCES INT'L., (HOLDINGS) INC.

(775)
  Report
Delayed Hong Kong Stock Exchange  -  03:08 2022-12-02 am EST
0.6900 HKD   -1.43%
11/28XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development opening a new paradigm for scientific innovation
AQ
11/24XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research and Development, Opening A New Paradigm for Scientific Innovation
CI
09/01CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee

09/01/2022 | 04:45am EST

The board of directors (the ‘Board') of CK Life Sciences Int'l., (Holdings) Inc. (the ‘Company') announced that with effect from 1st September, 2022, Mr. Colin Stevens Russel (‘Mr. Russel') retired as an Independent Non-executive Director of the Company (the ‘Retirement'). Upon his Retirement, Mr. Russel also ceased as a member of the Remuneration Committee of the Company (the ‘Remuneration Committee'). Mr. Donald Jeffrey Roberts, an Independent Non-executive Director of the Company, has been appointed as a member of the Remuneration Committee with effect from 1st September, 2022.

As at 1st September, 2022, the Executive Directors of the Company are Mr. Li Tzar Kuoi, Victor (Chairman), Mr. Kam Hing Lam, Mr. Ip Tak Chuen, Edmond, Mr. Yu Ying Choi, Alan Abel and Dr. Toh Kean Meng, Melvin; and the Non-executive Directors are Mr. Peter Peace Tulloch, Mrs. Kwok Eva Lee (Independent Non-executive Director), Mr. Kwan Kai Cheong (Independent Non-executive Director), Mr. Paul Joseph Tighe (Independent Non-executive Director) and Mr. Donald Jeffrey Roberts (Independent Non-executive Director).


ę S&P Capital IQ 2022
All news about CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
11/28XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and ..
AQ
11/24XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research..
CI
09/01CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Directo..
CI
08/02CK Life Sciences' H1 Profit Down 35%
MT
08/02CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30,..
CI
07/26CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each
MT
05/20CK LIFE SCIENCES INT'L., (HOLDINGS) INC. : Ex-divid..
FA
03/15CK Life Sciences Int'l., Inc. Announces Ordinary Final Cash Dividend for the Year Ended..
CI
03/15CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December..
CI
2021CK Hutchison : CK Asset profits rise in H1
RE
More news
Financials
Sales 2021 5 402 M 694 M 694 M
Net income 2021 163 M 20,9 M 20,9 M
Net Debt 2021 5 311 M 682 M 682 M
P/E ratio 2021 43,8x
Yield 2021 1,35%
Capitalization 6 632 M 852 M 852 M
EV / Sales 2020 2,77x
EV / Sales 2021 2,30x
Nbr of Employees 1 829
Free-Float 25,0%
Chart CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
Duration : Period :
CK Life Sciences Int'l., (Holdings) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Managers and Directors
Ying Choi Yu Chief Operating Officer & Vice President
Hing Lam Kam President & Executive Director
Yiu Leung Mo Chief Financial Officer
Tzar Kuoi Li Chairman
Kean Meng Toh Executive Director & Chief Scientific Officer
Sector and Competitors